SIC
IBB icon

Sterling Investment Counsel’s iShares Biotechnology ETF IBB Stock Holding History

Sterling Investment Counsel’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$230K Sell
1,211
-85
-7% -$14.6K 0.05% 184
2026
Q1 		$219K Sell
1,296
-12
-0.9% -$2.05K 0.06% 183
2025
Q4 		$221K Buy
+1,308
New +$212K 0.06% 173
2025
Q1 		– Sell
-1,521
Closed -$201K – 175
2024
Q4 		$201K Hold
1,521
– – 0.13% 126
2024
Q3 		$221K Hold
1,521
– – 0.08% 159
2024
Q2 		$209K Sell
1,521
-94
-6% -$12.5K 0.08% 155
2024
Q1 		$222K Sell
1,615
-156
-9% -$21.3K 0.1% 153
2023
Q4 		$241K Sell
1,771
-23
-1% -$2.81K 0.12% 130
2023
Q3 		$219K Hold
1,794
– – 0.13% 136
2023
Q2 		$228K Buy
1,794
+213
+13% +$27.7K 0.12% 135
2023
Q1 		$204K Hold
1,581
– – 0.12% 147
2022
Q4 		$208K Buy
+1,581
New +$204K 0.13% 145
2022
Q2 		– Sell
-1,685
Closed -$220K – 151
2022
Q1 		$220K Sell
1,685
-116
-6% -$15.1K 0.15% 137
2021
Q4 		$275K Buy
+1,801
New +$279K 0.19% 114

Other funds holding IBB

Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return
GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return
IHL
Investment House LLC Redondo Beach, California $2.21B AUM 39.6% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
AP
Appleton Partners Boston, Massachusetts $1.63B AUM 38.57% 1-Year Est. Return
FMI
Factory Mutual Insurance Waltham, Massachusetts $10.6B AUM 34.1% 1-Year Est. Return

Sterling Investment Counsel's IBB Position: Q2 2026 in Review

Sterling Investment Counsel reduced its iShares Biotechnology ETF (IBB) stake by 6.6% in Q2 2026, selling an estimated $14.6K and leaving 1,211 shares worth $230K. The position accounts for 0.05% of the portfolio, ranked #184.

Sterling Investment Counsel first reported a position in IBB in Q4 2021 and has held it in 14 quarters since. The position peaked at $275K in Q4 2021. 421 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Sterling Investment Counsel held 1,211 shares of iShares Biotechnology ETF worth $230K as of Q2 2026.
  • Sterling Investment Counsel sold 85 iShares Biotechnology ETF shares in Q2 2026, an estimated $14.6K.
  • iShares Biotechnology ETF made up 0.05% of Sterling Investment Counsel's portfolio in Q2 2026, its #184 holding.
  • Sterling Investment Counsel first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 14 quarters since.
  • Sterling Investment Counsel's iShares Biotechnology ETF position peaked at $275K in Q4 2021.
  • 421 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Sterling Investment Counsel's 13F filing for Q2 2026, filed 20 Jul 2026.